FDA
-
-
-
-
-
-
-
pSivida to Present at Rodman & Renshaw Annual Global Investment Conference
-
-
-
-
-
-
-
pSivida (PSDV) Submits MAA for Approval of Durasert Three-year Treatment for Posterior Segment Uveitis in EU
-
-
-
-
-
-
-
pSivida Corp. to Report Third Quarter Fiscal Year 2017 Financial Results on Thursday, May 4th
-
-
-
-
-
251,639 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All